NuvaRing: new combined hormonal contraceptive device
Authors
Abstract
NuvaRing is a new contraceptive device that delivers ethinylestradiol and etonogestrel and is inserted once every cycle for three weeks. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse effects and Dr Tina Peers comments on its place as a birth control option. Copyright © 2009 Wiley Interface Ltd
Digital Object Identifier (DOI)
10.1002/psb.526 About DOI
Login/Logout
Journal Menu
- Home
- News
- Current Issue
- Archive Issues
- Learning Central
- Ask Prescriber
- Prescriber Blog
- Forthcoming Events
- Supplements
- Wiley Job Network






